Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft
Public ClinicalTrials.gov record NCT00435942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1-year. Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent surgical repair. Long term follow-up is conducted through 5 years.
Study identification
- NCT ID
- NCT00435942
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 180 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Mar 31, 2011
- Completion
- May 14, 2017
- Last update posted
- Jan 15, 2018
2007 – 2017
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Heart Hospital | Phoenix | Arizona | 85006 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| University of California-San Francisco | San Francisco | California | 94143 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010-2975 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Baptist Cardiac and Vascular Institute | Miami | Florida | 33176 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Rockford Memorial Hospital | Rockford | Illinois | 61103 | — |
| Clarian Cardiovascular | Indianapolis | Indiana | 46202 | — |
| Indiana Heart Hospial | Indianapolis | Indiana | 46250 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| The Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| New York Presbyterian Hospital --Columbia/Cornell University | New York | New York | 10032 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| East Carolina University | Greenville | North Carolina | 27834 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Hospital of the University of Pennsylvania/Penn Presbyterian | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Methodist Hospital | Houston | Texas | 77030 | — |
| INOVA Fairfax Hospital | Falls Church | Virginia | 22042 | — |
| Sentara Heart Hospital | Norfolk | Virginia | 23510 | — |
| University of Washington | Seattle | Washington | 98105 | — |
| Aurora St. Luke's Hospital | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00435942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2018 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00435942 live on ClinicalTrials.gov.